Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

US Pharmaceuticals Ishares ETF (IHE)

US Pharmaceuticals Ishares ETF (IHE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family BlackRock iShares
  • Assets Under Management 576,380,700
  • Shares Outstanding, K 8,600
  • 60-Month Beta 0.70
  • Price/Earnings ttm 16.55
  • Annual Dividend & Yield 1.16 (1.72%)
  • Most Recent Dividend 0.292 on 03/18/25
  • Management Fee 0.39%
  • INDUSTRY GROUPING:

    ETFs - Biotech

Options Overview Details

View History
  • Implied Volatility 16.32% ( -5.82%)
  • Historical Volatility 34.43%
  • IV Percentile 69%
  • IV Rank 32.13%
  • IV High 49.42% on 04/09/25
  • IV Low 0.64% on 10/15/24
  • Put/Call Vol Ratio 999.99
  • Today's Volume 22
  • Volume Avg (30-Day) 14
  • Put/Call OI Ratio 2.05
  • Today's Open Interest 125
  • Open Int (30-Day) 143

Price Performance

See More
Period Period Low Period High Performance
1-Month
58.97 +15.10%
on 04/09/25
70.81 -4.14%
on 03/31/25
-0.68 (-0.99%)
since 03/28/25
3-Month
58.97 +15.10%
on 04/09/25
73.28 -7.37%
on 03/03/25
-1.38 (-1.99%)
since 01/29/25
52-Week
58.97 +15.10%
on 04/09/25
73.28 -7.37%
on 03/03/25
+4.14 (+6.50%)
since 04/29/24

Most Recent Stories

More News
How Is Gilead Sciences' Stock Performance Compared to Other Pharmaceutical Stocks?

As Gilead Sciences has outperformed its industry peers recently, Wall Street analysts maintain a moderately optimistic outlook on the stock’s prospects.

IHE : 67.88 (+1.34%)
GILD : 104.21 (-2.00%)
AMGN : 288.56 (+1.93%)
How Is Pfizer's Stock Performance Compared to Other Pharmaceuticals Stocks?

Pfizer has underperformed the pharmaceuticals industry over the past year, but analysts are moderately optimistic about the stock’s prospects.

IHE : 67.88 (+1.34%)
PFE : 23.79 (+3.21%)
BMY : 49.22 (+1.57%)
What Are Wall Street Analysts’ Target Price for Merck Stock?

Merck has considerably underperformed the broader market over the past year, but analysts are highly optimistic about the stock’s prospects.

$SPX : 5,560.83 (+0.58%)
MRK : 84.71 (+1.83%)
IHE : 67.88 (+1.34%)
ETFs Poised to Win or Lose Under Trump's New Policies

On Jan. 20, President Donald Trump commenced his second term by enacting a series of executive orders and repealing dozens of directives issued by former president Joe Biden, aimed at reshaping various...

XLE : 82.73 (-0.29%)
PBW : 15.93 (-0.50%)
IHE : 67.88 (+1.34%)
CARZ : 53.99 (+0.17%)
DRIV : 20.93 (+0.48%)
BITQ : 13.95 (-0.29%)
ICLN : 11.92 (-0.08%)
Eli Lilly Cuts Q4 Sales Forecast: ETFs to Buy on the Dip

Eli Lilly and Company LLY dropped 6.6% in the Jan. 14 trading session after slashing its revenue guidance for the fourth quarter and fiscal 2024, citing lower-than-expected sales for its weight-loss medicine...

OZEM : 24.78 (+2.76%)
IHE : 67.88 (+1.34%)
LLY : 885.20 (+0.90%)
MEDX : 26.64 (+0.48%)
PPH : 88.79 (+1.53%)
THNR : 21.84 (+2.52%)
Eli Lilly Stock: Is Wall Street Bullish or Bearish?

Eli Lilly has outperformed the broader market and its peers this year, and Wall Street analysts are bullish about the stock’s prospects.

$SPX : 5,560.83 (+0.58%)
IHE : 67.88 (+1.34%)
LLY : 885.20 (+0.90%)
Are Wall Street Analysts Predicting Johnson & Johnson Stock Will Climb or Sink?

Johnson & Johnson has struggled to keep up with the broader market over the past year, and analysts are cautiously bullish on its future potential.

$SPX : 5,560.83 (+0.58%)
JNJ : 155.91 (+0.36%)
IHE : 67.88 (+1.34%)
Bristol-Myers Stock: Is Wall Street Bullish or Bearish?

Bristol-Myers has underperformed the broader market over the past year, and analysts are cautious about the stock’s prospects.

$SPX : 5,560.83 (+0.58%)
IHE : 67.88 (+1.34%)
BMY : 49.22 (+1.57%)
Stocks and ETFs in Focus as Americans Head to Polls

Election Day has approached, and the polls indicate a tight race between Democratic Party candidate Kamala Harris and Republican nominee Donald Trump. Neither candidate holds a meaningful edge in enough...

KBWB : 60.76 (+0.80%)
BE : 18.91 (-1.72%)
CVX : 139.30 (-0.57%)
JPM : 244.62 (+0.58%)
MRK : 84.71 (+1.83%)
IHE : 67.88 (+1.34%)
PPH : 88.79 (+1.53%)
UNH : 409.23 (-2.56%)
PFE : 23.79 (+3.21%)
KBH : 53.25 (-1.24%)
XLE : 82.73 (-0.29%)
XHB : 93.90 (+0.14%)
ETFs in Focus Post JNJ Q3 Earnings Beat, Target Price Hike

Johnson & Johnson JNJ infused positive optimism for the broader healthcare sector after posting solid third-quarter 2024 earnings on Oct. 15. The world's biggest healthcare products maker continued with...

XLV : 139.28 (+0.49%)
JNJ : 155.91 (+0.36%)
IHE : 67.88 (+1.34%)
IYH : 58.13 (+0.55%)
PPH : 88.79 (+1.53%)
FTXH : 25.70 (+1.06%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Fund Summary

The iShares U.S. Pharmaceuticals ETF seeks to track the investment results of an index composed of U.S. equities in the pharmaceuticals sector. The Fund seeks investment results that correspond to the price and yield of the Dow Jones U.S. Select Pharmaceuticals Index.

See More

Key Turning Points

3rd Resistance Point 69.84
2nd Resistance Point 69.01
1st Resistance Point 68.44
Last Price 67.88
1st Support Level 67.04
2nd Support Level 66.21
3rd Support Level 65.64

See More

52-Week High 73.28
Last Price 67.88
Fibonacci 61.8% 67.81
Fibonacci 50% 66.13
Fibonacci 38.2% 64.44
52-Week Low 58.97

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar